Healthcare

Alzheimer Therapeutics Market Size to Attain USD 33.62 Billion by 2034

Healthcare

The global Alzheimer therapeutics market size is projected to experience robust growth, with expected market valuation hitting USD 33.62 billion by 2034 from USD 6.49 billion in 2025, growing at a CAGR of 20.06% between 2025 and 2034. This surge is primarily fueled by an increasing elderly population worldwide and revolutionary advances in disease-modifying therapies

Personalized Testing and Supplements Market Size to Attain USD 7.74 Billion by 2034

Healthcare, Press Release

Rapid Rise in Demand for Data-Driven Nutrition Spurs Industry Forecasts: North America Leads, Asia Pacific Surges The global Personalized Testing and Supplements Market is set to soar from $5.39 billion in 2025 to approximately $7.74 billion by 2034, growing at a relentless CAGR of 16.22%. The market’s acceleration reflects surging demand for wellness analytics and

Molecular Cytogenetics Market Size to Reach USD 7.82 Billion by 2034, Expanding at an 11.81% CAGR

Healthcare, Press Release

The global molecular cytogenetics market is poised for robust growth, driven by rising genetic disorder prevalence and advancements in genomic technologies for precise chromosomal analysis. Unlocking Genetic Insights: Molecular Cytogenetics Market on the Rise with High Growth Potential The molecular cytogenetics market size is valued at USD 2.86 billion in 2025, is projected to grow

Circulating Biomarkers Market Size to Attain USD 14.22 Billion by 2034

Healthcare

The global circulating biomarkers market size is projected to grow from USD 5.17 billion in 2025 to an impressive USD 14.22 billion by 2034, expanding at a robust CAGR of 11.90%. This growth is fueled by rising demand for early and non-invasive disease detection, increasing prevalence of chronic diseases, and breakthroughs in biomarker technologies. Circulating

AI in Telemedicine Market Size to Reach USD 176.94 Billion by 2034

Healthcare

The global AI in telemedicine market size is estimated at USD 26.11 billion in 2025 and is predicted to increase from USD 32.30 billion in 2026 to approximately USD 176.94 billion by 2034, expanding at a strong CAGR of 23.69% from 2025 to 2034. This expansion is fueled by increasing telehealth adoption, AI technology advancements, and growing

Incretin Mimetics Market Size to Surpass $38.01 Billion by 2034 Amid AI-Powered Drug Discovery and Diabetes Innovation

Healthcare

Surging Diabetes Prevalence and Technological Breakthroughs Propel Market to 5.07% CAGR Through 2034 The global incretin mimetics market is undergoing rapid transformation, on track to surge from $24.36 billion in 2025 to approximately $38.01 billion by 2034, a robust CAGR of 5.07%. With diabetes and obesity rates rising worldwide, advancements in GLP-1 analogs and AI-powered

Type 2 Diabetes Management Market Size and Forecast 2025 to 2034

Healthcare

The global Type 2 diabetes management market is projected for significant growth, driven by rising prevalence, technological advancements, and expanded healthcare initiatives. Valued at a substantial figure in 2024, it is forecast to witness a remarkable CAGR through 2034, propelled by innovations in drug therapies, medical devices, and digital management solutions. Introduction: Navigating Growth Amid

Next-generation Sequencing Library Preparation Market Size to Cross USD 6.44 Billion by 2034

Healthcare

The global next-generation sequencing (NGS) library preparation market size is projected to reach a valuation of USD 6.44 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.47% from USD 2.07 billion in 2025. This rapid growth is driven by technological advancements, increasing demand for high-throughput genomic analysis, and the expanding application scope

Scroll to Top